BMI is 0
The prediction of the benefit is only possible with a BMI between 30 and 50.
BMI is 0
The prediction of the benefit is only possible with a BMI between 30 and 50.
The risk predictions are based on a study using a primary care database of 570,000 UK adults.1
Based on whether they kept their weight stable or lost weight during a four-year baseline period, these individuals were assigned to two different groups. They were then followed for up to 15 years to observe differences between the groups regarding the development of 10 obesity-related comorbidities.1
Given the information you have specified about your patient, you see the average risk for individuals in the study population who are similar to them and who have either kept a stable body weight or lost on average 13% of their initial body weight.
In the study, the group of individuals losing weight, also had a medical record of weight loss diet, weight-loss diet, weight-loss drug prescription, or referral to a dietician or for bariatric surgery.
1. Haase CL, Lopes S, Olsen AH, et al. Weight loss and
risk reduction of obesity-related outcomes in 0.5 million people:
evidence from a UK primary care database. Int J Obes.
2021; 45:1249-1258. DOI: 10.1038/s41366-021-00788-4
The site you are entering is not the property of, nor managed by, Novo Nordisk. Novo Nordisk assumes no responsibility for the content of sites not managed by Novo Nordisk. Furthermore, Novo Nordisk is not responsible for, nor does it have control over, the privacy policies of these sites.
The information on this website is intended for healthcare professionals. If you are a healthcare professional and have not received the password, please e-mail Novo Nordisk Medical Information at nzlccc@novonordisk.com